You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
海辰藥業(300584.SZ):一季度淨利預降20%-30%
格隆匯 04-08 17:03

格隆匯4月8日丨海辰藥業(300584.SZ)披露2020年一季度業績預告,預計歸屬於上市公司股東的淨利潤1558.87萬元—1781.57萬元,同比下降20%-30%。業績變動原因如下:

1、公司主要產品為注射劑,終端客户為各級醫療機構。一季度,新冠肺炎疫情暴發,醫療機構的診療服務受到影響,許多患者取消或者推遲就醫,醫院門診量、手術量下降,藥品終端需求受到明顯影響。此外,疫情期間公司生產、物流配送、商業推廣受到一定程度限制,生產經營受到一定的影響,使得一季度銷售訂單減少,公司營業收入和利潤隨之下降。

2、報告期內,公司預計非經常性損益對淨利潤的影響金額約42萬元,影響較小。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account